scholarly journals Prescription Drug Monitoring Program: Registration and Use by Prescribers and Pharmacists Before and After Legal Mandatory Registration, California, 2010–2017

2018 ◽  
Vol 108 (12) ◽  
pp. 1669-1674 ◽  
Author(s):  
Aaron B. Shev ◽  
Garen J. Wintemute ◽  
Magdalena Cerdá ◽  
Andrew Crawford ◽  
Susan L. Stewart ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Prescription Drug Monitoring Program ◽  
Before And After

scholarly journals Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program

2021 ◽  
Vol 2 (10) ◽  
pp. e212924
Author(s):  
Rivfka Shenoy ◽  
Zachary Wagner ◽  
Allison Kirkegaard ◽  
Robert J. Romanelli ◽  
Satish Mudiganti ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Prescription Drug Monitoring Program ◽  
Before And After

scholarly journals Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines

2020 ◽  
Vol 3;23 (6;3) ◽  
pp. 299-304
Author(s):  
Alaa Abd-Elsayed
Keyword(s):  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
The United States ◽  
The State ◽  
Prescribing Patterns ◽  
P Value ◽  
Prescription Drug Monitoring Program ◽  
Before And After ◽  
Controlled Substance

Background: To date, there is limited research on whether the various types of mandatory usage of prescription drug monitoring programs (PDMP) have any effects on prescribing patterns, drug usage, patient care, and drug diversion (8-10). Within the United States (US), there is wide variation in individual states’ requirements for the usage of PDMPs. Objective: The objective of this study was to determine whether mandatory prescriber review of a PDMP prior to each issuance of a controlled substance resulted in a reduction in the total number of controlled substance prescriptions dispensed. Study Design: A retrospective review of the State of Wisconsin’s PDMP controlled substance database from April 2015 to March 2019 was performed. The evaluation compared the number of prescriptions among individual drug classes (opioids, benzodiazepines, stimulants) dispensed throughout the state before and after April 1st, 2017, when implementation of a state law mandating the review of the PDMP during each patient encounter prior to issuing a prescription for a controlled substance took effect. Setting: Research was conducted using Wisconsin’s PDMP controlled substance database from April 2015 to March 2019. During this time, controlled substance policy has come to the forefront of the nation due to issues with an opioid epidemic. Methods: Descriptive analysis was used to express data as n and % for categorical data and average ± standard deviation for numerical data. Before- and after-prescription totals were analyzed using a paired t test and Levene’s test for equality of variances. The P value was considered significant at a level ≤ .05. Limitations: Limitations to this study included its retrospective design, focus on a single US state, and possible unforeseen contributors to cause and effect. Results: Prior to the enforcement of the state’s mandatory PDMP legislation, an average of 844,314 controlled substance prescriptions were written monthly. Following the implementation of the law, the average monthly total prescriptions written within the state decreased to 708,063. This was an average monthly reduction of 136,251 prescriptions written or 16.1%. Statistically significant reductions were also seen in opioid and benzodiazepine subgroups (23.0%, 16.3%). Conclusion: Our study suggests that state-enforced mandatory usage of a PDMP, which records all controlled substance prescriptions filled by a pharmacy such as opioids, benzodiazepines, amphetamines, etc. at every encounter prior to prescribing any controlled substance, can provide for a significant reduction in controlled substance prescriptions, specifically opioids and benzodiazepines. Key words: Prescription drug monitoring program, opioids, mandatory usage, benzodiazepines, Wisconsin

A Review on Prescription Drug Monitoring Program

2021 ◽  
pp. 265-268
Author(s):  
Someshwar D. Mankar ◽  
Abhijit S. Navale ◽  
Suraj R. Kadam
Keyword(s):  
Systematic Review ◽  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Opioid Abuse ◽  
Prescription Opioid ◽  
Prescription Drug Monitoring Program ◽  
Prescription Opioid Abuse

Nowadays Prescription Opioid Abuse has become a serious problem, to monitor and reduce Opioid Abuse most of countries developed Prescription Drug Monitoring Program (PDMP). Regarding to this we conduct a systematic review to understanding the PDMP impact in order to reduce Opioid Abuse and improving prescriber practices. This review can help to guide efforts to better response to the Opioid crises.

scholarly journals Clinical Styles and Practice Policies: Influence on Communication with Patients Regarding Worrisome Prescription Drug Monitoring Program Data: Table 1

Pain Medicine ◽  
2016 ◽  
Vol 17 (11) ◽  
pp. 2061-2066 ◽  
Author(s):  
Christi Hildebran ◽  
Gillian Leichtling ◽  
Jessica M. Irvine ◽  
Deborah J. Cohen ◽  
Sara E. Hallvik ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Data Table ◽  
Prescription Drug Monitoring Program ◽  
Program Data

scholarly journals 249 EMF Usability of the Massachusetts Prescription Drug Monitoring Program in the Emergency Department

2015 ◽  
Vol 66 (4) ◽  
pp. S90
Author(s):  
S.J. Poon ◽  
M.B. Greenwood-Ericksen ◽  
R.E. Gish ◽  
P.M. Neri ◽  
S.S. Takhar ◽  
...  
Keyword(s):  
Emergency Department ◽  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Prescription Drug Monitoring Program
Sign in / Sign up

Export Citation Format

Share Document